SEC Form 4 · accession 0001144204-18-045375
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrade
Officer — Chief Financial Officer
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2018 | M | 17,050 | $1.44 | A | 17,050 | D |
Table II — derivative securities
No Table II lines on this filing.